A spectrum of treatment plans and surgical procedures are available for management of laryngeal cancer. Transoral laser resection has proved an effective, minimally invasive and functionally satisfactory procedure for management of suitable T1 and T2 glottic cancers, and stage I-III supraglottic cancers. Introduction of chemoradiotherapy has also made great impact on the laryngeal preservation. The treatment of laryngeal cancer should be individualized according to the size and extent of the tumor, the age and physical condition of the patient, and the skill and experience of the surgeon with various treatment modalities and surgical procedures.
Management of cancer of the supraglottic. Otolaryngol Head Neck Surg 2001;124:195–98.
Update in Head and Neck Cancer: 2008, presented by Massachusetts Eye and Ear Infirmary, 2008;41(19).
Transoral laser surgery for supaglottic cancer. Head Neck 2008 May;30(5):658–66.
Results of an organ conservation protocol in patients with locally advanced laryngeal tumors. Acta Otorrinolaringológica Española 2009;60(3):176–85.
Total laryngectomy and postoperative radiotherapy for T4 laryngeal caner: 4 14 years review. Am J Otolaryngol 2004 Mar;25(2):88–93.
Oncology 1995;9(6): 547–58.
Classification of neck dissection 1993 Dec.
Organ preservation surgery for laryngeal cancer. Head and Neck Oncology 2009; 1:12.
Treatment of head and neck cancers. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds: Cancer: Principles and Practice of Oncology. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2005;662–732.
Radiation Therapy for Head and Neck Neoplasms. 3rd ed. New York: Wiley-Liss, 1997.
Comprehensive Management of Head and Neck Tumors (2nd ed). Philadelphia, PA: WB Saunders, 1999.
The value of combining radiotherapy with surgery in the treatment of hypopharyngeal and laryngeal cancers. Cancer 1983;51(10): 1819–25.
Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group. J Clin Oncol 1994;12(8):1592–99.
Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 1996;88(9):583–89.
A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results. Head Neck 1997; 19(7):567–75.
Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 2000;18(7):1458–64.
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349(22): 2091–98.
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350(19): 1945–52.
Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355 (9208):949–55.